H
eart failure is a chronic, progressive condition that represents a major health burden in the United States, 1 resulting most often in eventual death. Heart failure is characterized by impaired myocardial function despite the compensatory adaptation of myocyte hypertrophy. One potential explanation for this paradox is suggested by the observation that interstitial fibrosis accompanies cardiac hypertrophy in heart failure [2] [3] [4] and other pathologic conditions associated with cardiac dysfunction 5, 6 but is absent from hearts in which the stimulus for hypertrophy is exercise training 7 or hyperthyroidism. 8 Moreover, cardiac hypertrophy resulting from exercise training or hyperthyroidism is characterized by enhanced myocardial function. Thus it has been hypothesized that the accumulation of extracellular matrix proteins leading to intersititial fibrosis represents a major contributing cause of myocardial dysfunction in heart failure. 9 Efforts to define causality and attempts to understand the mechanisms of fibrotic development in pathologic cardiac hypertrophy have been thwarted by a paucity of appropriate animal models that accurately parallel the progression from stable compensated hypertrophy to myocardial dysfunction and congestive heart failure in humans; that is, animal models of heart failure largely fail to mimic the gradual progression to decompensation observed in human disease covering a major portion of the life span. 1 The SHR is a model that exhibits compensated cardiac hypertrophy for more than 50% of its life span, ultimately developing cardiac dysfunction and congestive heart failure at a mean age of 21 months. 10, 11 In the SHR model, the transition to heart failure is characterized by a marked upregulation in the expression of genes that regulate or constitute extracellular matrix. 12 The SHR model can be criticized, however, as the genetic basis responsible for the development of hypertension in this strain is unknown. In addition, SHR develop heart failure only after more than 12 months of hypertension (between 18 and 24 months of age), suggesting that age-associated changes in the heart contribute significantly to the development of failure.
Although the SHR will continue to serve as a useful model of the transition from stable compensated hypertrophy to heart failure, we sought another model that would develop failure slowly over time but that was not subject to the limitations imposed by a genetic model of hypertension. The purpose was to determine whether chronic pressure overload introduced gradually in young normotensive rats would lead predictably to heart failure and exhibit phenotypic features associated with heart failure. A second goal was to identify functional and phenotypic characteristics of heart failure that differ from those observed in SHR of advanced age. To this end, we studied male Wistar-Kyoto rats that undertwent banding of the ascending aorta at 7 weeks of age. The band was sized such that at the time of application it imposed little or no restriction to aortic flow. As the animals grew, the relative severity of the constriction increased, resulting in cardiac hypertrophy. Approximately 50% of these rats exhibited clinical and pathologic signs of congestive heart failure between 7 and 20 months of age. Animals with heart failure were compared with age-matched nonbanded control rats and to age-matched aorta-banded rats with hypertrophy but not failure. Despite genetic differences, rats with chronic aortic constriction, like the SHR model of heart failure, exhibit augmented hypertrophy, depressed contractile function, elevated fibrosis, increased myocardial stiffness, and marked alterations in the expression of genes encoding contractile, regulatory, and extracellular matrix proteins.
Materials and Methods

Animals
Male Wistar-Kyoto (WKY) rats were purchased from Taconic (Germantown, NY). At approximately 7 weeks of age the animals underwent surgery at the Taconic facility. Under anesthesia, a thoracotomy was performed and a silk band placed around the ascending aorta. A specially constructed 18.5-gauge needle was placed next to the aorta, and a silk band was tied tightly around the needle and the aorta distal to the innominate artery. The needle was subsequently removed, thereby standardizing the diameter within the silk band. The rats were boarded at Taconic for 3 weeks after surgery before shipment to the animal facility at the Veterans Affairs (VA) Boston Healthcare System. All groups of rats (banded and nonbanded) were then housed two per container and fed regular rat chow and water.
Nine rats that had not undergone operation were initially designated as controls. The banded animals were divided into two groups based on the presence or absence of congestive heart failure. The banded animals were observed several times per week for evidence of tachypnea and labored respiration; if a banded rat exhibited these signs, it was killed. Another banded rat without tachypnia or labored respirations and a control rat were killed at approximately the same age. In this manner, the aortabanded group (AoB) was divided into two equal agematched groups of rats with hypertrophy but not yet heart failure (AoB-Hyp) and rats with signs of failure (AoB-F). Tachypnia and labored respiration were very predictive of heart failure but were not the only criteria. The final group assignments were based on autopsy observations of right ventricular (RV) hypertrophy (explained later). Ultimately, the control group consisted of four aortic-banded rats without LV hypertrophy (in which case it is assumed that the band was misplaced or came loose), and nine animals that had not undergone operations.
Increased RV weight has been the most consistent feature of SHR studied with heart failure. [11] [12] [13] [14] Therefore, for the present study, aorta-banded animals were considered to be in failure (AoB-F) if they exhibited increased RV weight as evidenced by the ratio of RV weight to body weight (RV/BW) Ͼ0.75 and of RV to tibial length (RV/ TL) Ͼ0.18. All 13 rats in the AoB-F group demonstrated rapid labored respirations (Table 1 ). Eight of 13 had left atrial thrombi, and three of 13 had pleural or pericardial effusions or both. Grossly visible fibrosis often involving the papillary muscles was present in 12 of 13 AoB-F. Of the 13 AoB-Hyp rats, three had labored respirations and none had atrial thrombi or pleural effusions. Six of 13 hearts demonstrated minimal-to-moderate visible fibrosis. Of the 13 animals in the control group, none had rapid respirations, atrial thrombi, effusions, or visible fibrosis. All 39 animals reported in Table 1 were studied, and a subset was used for the papillary muscle studies in Tables  2 to 4 based on papillary muscle criteria stated in the next section.
After rats were killed, hearts were quickly removed and placed in oxygenated Krebs-Henseleit solution at 28°C. The left ventricular (LV) papillary muscles were dissected and mounted as described later here. The heart was dissected into the atria and the left and right ventricles. Tissue samples were gently blotted and weighed. Samples of the left and right ventricles were frozen in liquid nitrogen.
Samples of the left and right ventricles, atria, lung, and liver were dried at 60°C for 24 h, after which the water content and dry left and RV weights were calculated. Left and RV wet weights normalized by body weight (LV/BW and RV/BW) and dry weight by tibia length (LV/TL and RV/TL) were used as indices of ventricular hypertrophy. Two tibias were frozen at the time of study for subsequent x-ray examination and measurement of tibial length. All procedures followed were in accordance with guidelines for animal research at the VA Boston Healthcare System.
Papillary Muscle Mechanics
Papillary muscles were selected from the anterior or posterior left ventricle. Only data from animals with papillary muscles of similar cross-sectional area (between 1.0 and 2.0 mm 2 ) were compared so as to avoid concerns that differences in papillary muscle diffusion distance may have contributed to differences in function. Thus, the study population of papillary muscles did not differ significantly in diameter among the groups. The methods used for assessing isolated papillary muscle function have been described in detail. [13] [14] [15] [16] Briefly, an LV papillary muscle was dissected free, mounted between two spring clips, and placed vertically in a 100-mL acrylic chamber containing Krebs-Henseleit solution at 28°C oxygenated with a mixture of 95% O 2 and 5% CO 2 (pH 7.38). Muscles were stimulated at a rate of 12/min by parallel platinum electrodes delivering 5-msec pulses at a voltage 10% above threshold and were gradually stretched to the peak of the active tension-versus-length curve (L max , defined as the muscle length resulting in the peak active tension). Once a stable L max was determined, the muscle contracted isometrically at L max and the resultant isometric contraction parameters of five twitches were determined and averaged. These included resting tension (RT, g/mm 2 ), active tension (AT, g/mm 2 ; defined as peak isometric tension minus resting tension), peak rate of isometric tension development (peak (ϩ)dT/dt, g/mm 2 /sec), electromechanical delay (EMD, msec; defined as the time from stimulation to the onset of tension development), time to peak tension (TPT, msec; defined as the time from the onset of tension development to the time of peak tension), and time from peak tension to 50% relaxation (RT 1/2 , msec). Forcevelocity relations (shortening velocity versus load) were determined from shortening velocity measurements after "quick releases" to loads ranging from 0.5 g to peak isometric tension performed 100 msec after stimulation.
Central Segment Measurements
After these determinations, central segment markers were applied to the muscle preparation. The central segment scanning system used for these studies is similar to that described by Wiegner and Bing. 16 Passive tension-length relations were determined by applying length ramps to the whole papillary muscle at a rate of 1.0 mm/sec, corresponding to a normalized rate of length change on the order of 0.1 muscle lengths/sec. Tension and central segment stress-strain relations were derived from these measurements as previously described.
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Histologic Studies
At the conclusion of the mechanical studies, muscles to undergo histologic analysis were mounted vertically with load corresponding to the resting tension at L max fixed in Karnovsky fixative (1% paraformaldehyde and 1.26% glutaraldehyde in 0.1 mol/L sodium cacodylate buffer at pH 7.4) and then stored in 0.1 mol/L sodium cacodylate buffer. The blocks were then embedded in paraffin. Sections 1 m thick were prepared for microscopy as previously described. 17, 18 The central segment was used for histology and morphometric analysis. Sections of central segments and LV wall were stained with Masson's trichrome; some were embedded in Epon and stained with methylene blue-azure II/basic fuchsin. These stains facilitate morphometry by permitting a clear distinction between interstitium and muscle fibers. Quantitative estimates were obtained by counting the frequency of interstitium and myocardium at the intersections of an optical grid. The grid had 36 points; at least 10 fields of each slide were counted using a 40ϫ objective. Fractional area is expressed as the ratio of points of interstitium and myocardium to total points counted.
Hydroxyproline Determinations
Hydroxyproline content of LV wall samples was determined by using a modified Stegemann procedure. AoB-F ϭ aorta-banded rats in heart failure; AoB-Hyp ϭ aorta-banded rats with hypertrophy but not yet heart failure. Table 2 . Animal weights, chamber weights, and ratios Table 1 Data are mean Ϯ SD. AT ϭ active tension; CSA ϭ muscle cross-sectional area; ϩdT/dt ϭ peak positive derivative of tension; RT ϭ resting tension; RT 1/2 ϭ time from peak tension to 50% relaxation; TPT ϭ time from onset of contraction to peak tension; V 0.5 ϭ shortening velocity, determined from quick releases to 0.5 g/mm 2 at 100 msec (normalized by muscle length at L max ); other abbreviations as in Table 1 . Data are mean Ϯ SD and are from muscles matched for cross-sectional area. * P Ͻ .05 v control; † P Ͻ .05 v AoB-Hyp; ‡ P Ͻ .01 v AoB-Hyp; § P Ͻ .01 v control.
LV wt
Briefly, a sample of LV myocardial tissue weighing 200 to 300 mg was homogenized, and hydrolysis of the sample solution was carried out with 6 N HCl at 100°C for 24 h. The hydrolyzed samples were dried using a flash evaporator. The amount of hydroxyproline in unknown samples was calculated using a standard curve and expressed as milligrams per 100 mg tissue dry weight.
Extraction of Collagen
Reference-grade collagen standards were obtained from Calbiochem (San Diego, CA). All experiments were done with the same area of the LV tissue. The extraction and phenotyping of collagen was performed using the procedure described by Laurent et al. 20 According to this method, sodium dodecyl sulfate was shown to remove the bulk of noncollagen protein, leaving an insoluble residue, which could then be reacted with cyanogen bromide without further purification. In addition, cyanogen bromide was shown to solubilize essentially all of the collagen in the residue, leaving an insoluble pellet, the aminoacid analysis of which has been shown to be similar to that of elastin.
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Digestion of Collagen With Cyanogen Bromide
The acetone-dried powder was homogenized in an allglass homogenizer with 0.6 mL of 70% vol/vol of formic acid per 100 mg of original tissue. The homogenate was transferred to a 15-mL graduated polyethylene centrifuge tube, and any remaining residue was washed from the homogenizer with 0.6 mL of formic acid. Homogenate was made up to a volume of 1.5 mL with 70% vol/vol formic acid per 100 mg of original tissue. Cyanogen bromide crystals were added to this volume to produce a concentration of 20 mg/mL. Nitrogen gas was then bubbled through the mixture, tubes were sealed, and the reaction was allowed to proceed for 18 h at 25°C. Tissues were digested for 18 hours. To facilitate mixing, the tubes were positioned at an angle of 30 degrees. When the reaction was completed, the digest as centrifuged at 5000 g for 20 min. The stopper was removed in a fume cupboard, and 0.3 mL of the supernatant was removed and dried under vacuum in a 1.5-mL microfuge tube. This was then directly dissolved in sample buffer in preparation for polyacrylamide gel electophoresis. The amount loaded was determined by hydroxyproline estimation on the lyophilized powder obtained from 0.5 mL of supernatant.
Collagen Typing
Polyacrylamide gel electrophoresis was performed on vertical gels (Protean II, Biorad, Richmond, CA) by stacking and separating gel concentrations of 4% and 12%, respectively. The gels were 1.5 mm thick, with 15 sample wells. Samples of a volume of 10 L were loaded into the wells using a Hamilton microsyringe, and stacking was allowed to occur at a current of 25 mA. Once the samples entered the separating gel, the current was increased to 35 mA, and electrophoresis continued until the dye marker reached a level two-thirds from the top. When electrophoresis was complete, the gel was removed and stained for 1 h by gentle shaking in 250 mL of an aqueous solution containing 0.124% Coomassie Blue R 250, 50% methanol, and 10% acetic acid. Using several changes of acetic acid, the gel was de-stained for 24 to 48 h by continuous shaking. All staining and de-staining reactions and all gel buffers were filtered to minimize contamination for subsequent scanning. Gels were scanned using Quick Scan (Helena Laboratories, Beaumont, TX). The quantitation of relative amounts of Type I:III collagen was accomplished by determining the relationship between the amount of collagen applied to the gel and that found in the relative peak, a relationship that was distinctive for the collagen types.
RNA Blotting
The RNA was isolated from left and right ventricles by the method of Chomzynski and Sacchi. 21 Quantities of 10 g of total RNA was size-fractionated by electrophoresis through 1% agarose gels, transferred electrophoretically at 5 V/cm to a nylon membrane, and hybridized with 32 P-radiolabeled probes overnight at 63.5°C for cDNA probes and 60°C for oligonucleotide probes. 22 Hybridization intensity was quantified in disintegrations per minute directly from blots using a Betascope 603 (Betagen Corp., Waltham, MA). The Betascope 603 contains an electronic sensor that responds to beta radiation from all areas of the blot directly with an efficiency of at least 15%. Signals visualized on computer screen were identified by position relative to 18S and 28S rRNA migration, delineated by Table 1 . Data are mean Ϯ SD. Heart, lung, and liver water content (expressed as g water/g dry tissue weight). * P Ͻ .001 v control; † P Ͻ .001 v AoB-Hyp.
squares 9 ϫ 9 mm, and quantified. Each blot was subsequently stripped and reprobed. The signal from each sample was normalized to the signal obtained with a probe specific for the 18S ribosomal RNA.
Probes
Complementary DNA probes were synthesized from a template by the random prime method. 23 The templates for the ␣-cardiac actin, ␣-skeletal actin, and atrial natriuretic factor probes were 180 to 700 bp cDNA sequences obtained by polymerase chain reaction (PCR) using primers complementary to the published sequences for rat mRNA. [24] [25] [26] The PCR-generated probe sequences were verified by DNA sequence analysis. The fibronectin probe was a 2.2-kb product of an EcoR1 digest of the 3-kb pRCabFN2 clone generously supplied by K. Boheler. This probe does not distinguish between alternatively spliced fibronectin mRNA variants. To identify EIIIAϩ fibronectin mRNA, an oligonucleotide specific for this segment was constructed with the following sequence 27 :5=CCACCGTGCAAG-GCAACCACACTGACTGTGTACTCAG3=. The probes for pro-␣1(I) and pro-␣1(III) collagen were cDNA kindly provided by M.-L. Chu. 28, 29 The probe for transforming growth factor-␤ (TGF-␤ 1 ) was generously provided by M. Sporn. 30 The myosin light-chain-2 (MLC-2) probe was a cDNA probe encompassing the entire translated region of rat cardiac myosin light-chain-2 (pMLC-D2) and was generously provided by K.R. Chien (San Diego, CA). 31 The probes for ␣-myosin heavy chain (␣-MHC), ␤-myosin heavy-chain (␤-MHC), and the 18S ribosomal RNA were end-labeled synthetic oligonucleotides. 32 The probe for cardiac sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA) was also a synthetic end-labeled oligonucleotide complementary to the terminal 33 bases of the coding portion of the rat gene with the sequence: 5= CTC CAG TAT TGC AGG CT.
Statistical Procedures
Data are presented as mean Ϯ SD. One-way analysis of variance was used to determine differences among the three groups. Post hoc comparisons between groups were made using the Newman-Keuls multiple comparison test.
Results
Model Characteristics
There was no significant difference in age among the three groups ( Table 1 ). The LV weight was significantly increased in the AoB-Hyp and AoB-F groups as compared with control (Table 2 ). In addition, AoB-F LV weight was significantly increased as compared with AoB-Hyp. The RV weights in the AoB-F group were significantly higher than in the AoB-Hyp and control groups. Left ventricular hypertrophy was found in both AoB-F and AoB-Hyp groups as compared with the control as manifested both by LV/BW and LV/TL and significantly increased in AoB-F over AoB-Hyp. Increased RV weight, as manifested both by RV/BW and RV/TL, was present in the AoB-F group as compared with both the AoB-Hyp and control.
Both LV and liver water content were increased in the AoB-F group compared with the AoB-Hyp and control (Table 4 ). There were no differences in lung water content or in RV water content.
There were clear physiologic distinctions between the AoB-Hyp and AoB-F groups. Active tension development and maximal shortening velocity were significantly depressed in the AoB-F group relative to the other two groups. In addition, central segment muscle stiffness (K cs ) was significantly increased in the AoB-F group in comparison to both control groups. There were no significant differences in contraction parameters between the control and hypertrophied groups. This finding is similar to that of Julian et al, 33 who studied rabbits with chronic RV hypertrophy after placement of a nonconstricting pulmonary artery band and found no functional differences between control and hypertrophied RV muscle preparations.
Isolated Muscle Contraction Parameters
The LV papillary muscle preparations from control (n ϭ 8), AoB-Hyp (n ϭ 8), and Aob-F (n ϭ 11) groups of similar cross-sectional areas were compared (Table 3) , thus avoiding concerns that differences in diffusion distance to the muscle core may have contributed to differences in function. Resting tension was slightly but significantly increased in AoB-F versus control. Active tension was decreased in AoB-F versus AoB-Hyp. Peak rate of isometric tension development was decreased in the AoB-F compared with both control and AoB-Hyp. Time to peak tension increased in the AoB-F when compared with control. Time to 50% relaxation was significantly shortened in the AoB-Hyp compared with control, and in the AoB-F compared with either control or AoB-Hyp. Shortening velocity was reduced in AoB-F compared with control and in AoB-F compared with AoB-Hyp.
Myocardial Fibrosis and Stiffness
Fibrosis was increased in the AoB-F group as demonstrated by a significant increase in collagen content compared with AoB-Hyp and control. Mean histologic interstitial space was approximately doubled in AoB-F compared with the other two groups, but because of variability in the measurement this did not reach statistical significance (Table 5) . To assess the effect of fibrosis on myocardial function, central segment stiffness of papillary muscles was evaluated. Central segment stiffness was increased in AoB-F compared with both control and AoBHyp (Table 5 ). There was no significant difference for K cs between AoB-Hyp and control.
Gene Expression
To determine the pattern of gene expression during the transition to heart failure in these rats, the levels of mRNA were measured by RNA blotting. Levels of fibronectin mRNA in the LV did not differ among the three groups ( Table 6 ). Levels of ␣ 1 (I) collagen mRNA were elevated 35% in the LV of AoB-Hyp rats, but in the LV of AoB-F rats the levels of ␣ 1 (I) collagen mRNA did not differ from control values. Levels of ␣ 1 (III) collagen mRNA were elevated 43% in the LV of AoB-F but not in those of AoB-Hyp rats. Levels of TGF␤ 1 mRNA were elevated 29% in the LV of AoB-Hyp rats compared with control rats, and further elevated in the LV of AoB-F rats (59% of control). Thus, only two of these genes that encode extracellular matrix proteins or regulatory molecules exhibited an increase during the transition to failure, namely, TGF␤ 1 and ␣ 1 (III) collagen.
Levels of atrial natriuretic factor (ANF) mRNA were elevated nearly 367% in the LV of AoB-Hyp rats compared with control values and were further elevated in hearts of AoB-F rats (628% of control) ( Table 7) . Compared with control values, the levels of ␣-and ␤-MHC MRNA were depressed in hearts of both AoB-Hyp (Ϫ41%) and AoB-F groups (Ϫ75%). Whereas levels of ␣-MHC mRNA were further depressed in AoB-F compared with AoB-Hyp rats, there was no difference in the level of ␤-MHC mRNA between the AoB-Hyp and the AoB-F groups. The levels of SERCA mRNA were decreased by 22% in the LV of AoB-Hyp rats and further depressed (Ϫ46%) in AOB-F rats compared with the control values. The levels of skeletal ␣-actin mRNA were increased (ϳ100%) in both the AoB-Hyp and AoB-F groups compared with control, but there was no difference between the two AoB groups. There were no differences among the three groups in the levels of cardiac ␣-actin or MLC-2 mRNA.
Discussion
Major Findings
In this study, hearts of aorta-banded rats that underwent a transition from stable compensated hypertrophy to heart failure were characterized by augmented hypertrophy, depressed contractile function, elevated fibrosis, increased myocardial stiffness, and marked alterations in the expression of genes encoding contractile, regulatory and extracellular matrix proteins. Despite differences in genotype, the ultimate phenotype associated with the transition to failure in the aorta-banded rat is nearly identical to that observed in the aged SHR, 11, 12, 13 with notable differences in the expression of several genes. Gradual constriction of the rat aorta resulted in heart failure after a variable length of time that averaged 9 months and ranged from 3 to Ͼ18 months. Although the variable time course of heart failure may limit the usefulness of this model for future studies, several important observations were made. The findings suggest that a common heart failure phenotype follows long-term pressure overload regardless of the underlying etiology.
Papillary Muscle Function
Impaired papillary muscle function is a defining characteristic of the failing heart that correlates well with im- Table 1 .
Values are means
paired global heart function of the same hearts. 11 The hearts of the AoB-F group meet the functional criterion for failure because isolated papillary muscles from these rats exhibited a diminished ability to generate force and a slower rate of force generation compared with control or AoB-Hyp groups ( Table 3 ). The magnitudes of the deficits in contractile function are very similar to those observed in the aged SHR model of heart failure. 13 From a functional perspective, therefore, the aortic banding model of heart failure appears to be quite similar to the SHR model of heart failure.
Extracellular Matrix
Heart failure in the aorta-banded rats was associated with a significant increase in collagen content that corresponded to a significant increase in papillary muscle stiffness (Table 5 ). These data and the trends toward an increase in interstitial area and a decrease in myocyte area are similar to previous findings in failing hearts of SHR. 13 There were also significant increases in the levels of mRNA encoding some of the extracellular matrix-related proteins, indicating that there is regulation of matrix accumulation in the failing hearts of AoB-F rats at the pretranslational level. Contrasting the many similarities between the AoB and the SHR models of failure, marked differences in the changes in levels of several extracellular matrix mRNA during the transition to failure were observed (discussed later here). Progressive fibrosis appears to play an important role in the transition to heart failure in the aorta-banded rat model, 34 as it does in human heart failure.
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Implications for Aging
Although age has been recognized as the leading risk factor for heart failure, the contribution of age-related factors to the development of heart failure remains poorly defined. 35 The present study offers the opportunity to compare the changes that occur in this AoB model of adult (11-month-old) rat heart failure to other studies in which heart failure occurs in younger or older rats. The most direct comparison can be made between the present study and previous observations made of the aged (19 to 21 months) SHR, because many of the same variables were measured. [11] [12] [13] [14] It is also instructive to compare the present study to studies of heart failure in 5-month-old aortaconstricted rats 36 to gain a perspective covering most of the rat life span. The vast majority of changes in function, structure, and gene expression associated with the transition to heart failure are comparable in the 11-month-old AoB-F and the 19-to 21-month-old SHR. [11] [12] [13] [14] The most striking differences are observed in the responses of fibronectin and collagen Types I and III gene expression. Although the levels of mRNA encoding each of the three extracellular matrix proteins are markedly increased in the aged SHR during the transition to failure, only the levels of mRNA encoding collagen Type III are significantly elevated in the AoB model of heart failure and to a much lesser degree than observed in the aged SHR. Both models of heart failure exhibit fibrosis; however, this comparison suggests that the manner in which the connective tissue accumulation is regulated may be different in middle-aged AoB rats compared with aged SHR progressing to heart failure.
Relaxation of the heart depends on reuptake of calcium into the sarcoplasmic reticulum by the SERCA pump. The dynamics of SERCA expression and their functional consequences are of great interest because the expression of SERCA is depressed in failing human hearts and is thought to play a critical role in the etiology of human failure. [37] [38] [39] The present results are similar to findings by several investigative groups in young aorta-banded male Wistar rats; these investigators showed that levels of both mRNA and protein for SERCA were depressed during pressure-overload hypertrophy. 40 -42 The present results extend the earlier findings in that SERCA mRNA levels are significantly decreased in AoB-Hyp compared with control and are further decreased during the transition to failure. The present findings regarding SERCA gene expression represent another striking difference between the AoB and SHR models of heart failure that may be attributable to age. Although SERCA expression was prominently diminished in the hearts of middle-aged AoB-F rats compared with age-matched AoB-Hyp rats in the present study, SERCA mRNA levels were not significantly depressed in hearts of aged SHR during the transition to failure relative to age-matched SHR without heart failure. 12 The most likely explanation for the lack of a decrease during the transition to heart failure in the SHR model is that the levels of SERCA are already depressed in both the WKY and SHR at 18 to 24 months of age because of the well-known effect of advancing age on SERCA expression. 43 It should be noted that factors other than the ageassociated possibilities enumerated above are also likely to contribute to the differences observed between the AoB and SHR models of heart failure. For example, the nature and time course of the hemodynamic load imposed by chronic hypertension are different from that due to aortic constriction. 44 Another factor that differs between the SHR and the present AoB model is the genetic cause of hypertension, which likely involves multiple genes including a lack of CD36 in the hearts of SHR.
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Expression of Hypertrophy-Associated Genes
As predicted, the expression of ANF mRNA is increased whereas that of ␣-MHC mRNA is decreased in the LV of AoB-Hyp rats. Also as expected, changes in LV ANF and ␣-MHC expression are exacerbated during the transition to failure in AoB-F rats. Similar changes in expression of ANF and ␣-MHC are observed in failing hearts of older SHR rats 12 and of younger aorta-constricted rats, 40, 47 indicating that the expression of these genes retains an adaptive reserve across a wide age range in rats, despite their well-known changes in the same direction with advancing age. 35 The expression of ␤-MHC mRNA is decreased ϳ40% in the LV of 11-month-old AoB-Hyp and AoB-F rats alike, in contrast to a marked increase in ␤-MHC mRNA observed in 5-month-old aorta-constricted rats with failure. 40 Expression of ␤-MHC mRNA is not altered during the transition to failure in 20-month-old SHR. This most likely reflects the fact that the expression of ␤-MHC mRNA is very low in the LV of young rats and is markedly upregulated with advancing age. 32 During the transition to failure in both middle-aged and older rats, therefore, the myosin protein isoform changes that occur are primarily regulated by the decrease in expression of ␣-MHC mRNA. The expression of skeletal ␣-actin in the cardiac ventricles is commonly associated with nascent hypertrophy. 48, 49 The twofold increases in skeletal ␣-actin expression in both AoB groups in the present study suggesting that a subpopulation of myocytes are in the initial phase of hypertrophic growth even after a long period of established hypertrophy.
Hearts of young aorta-banded rats that underwent a gradual transition from stable compensated hypertrophy to heart failure in middle age were characterized by augmented hypertrophy, depressed contractile function, elevated fibrosis, increased myocardial stiffness, and marked alterations in the expression of genes encoding ␣ 1 (III) collagen, TGF␤ 1 , and SERCA, ANF, and ␣-MHC. Comparison of the current results from this aorta-banding model of heart failure in middle-aged rats to those in the aged SHR and to younger aorta-banded rat models reveals differences in the expression of several genes that differ- entiate the models and that may be attributable, at least in part, to age. Despite differences in gene expression among models of heart failure, the phenotypes associated with the transition to failure are, ultimately, remarkably similar.
